Pioneering the next step in modern medicine, treat chronic wound patients, and kill multi-resistant bacteria, supported by EIT Health
EIT Audience Award winner Carsten Mahrenholz believes it’s a problem that demands more attention, and the cold plasma technology developed by his start-up, ColdPlasmatech, is creating waves around the world.
In the time since receiving their award at INNOVEIT, the company has made great strides, including receiving funding from the Federal Ministry of Science and Education in Germany to conduct clinical and economic trials and the first live production of their plasma patches. We caught up with Mahrenholz to learn more about progress and how EIT Health has supported them on their journey.
The Star Trek-like medical device that uses cold plasma to kill multi-resistant bacteria and treat even chronic wounds. It’s not an idea – it’s real.
Want to read more about ColdPlasmatech?